NYSE:HAE

74.45
1.66 (2.18%) 1d
0
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 18/21, Up 6.23%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HAE, has triggered its stop at $60. To remain disciplined, we recommend covering the position at this time. We will look for better opportunities.
Healthcare
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 18/21, Up 19.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HAE is progressing well. We now recommend trailing the stop (from $40) to $60. If triggered, this would all but guarantee a marginal return on the original recommended entry.
Healthcare
BUY
They had a weak quarter, but have performed well over time. He's known them forever and would buy it.
Healthcare
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly HAE stock prices took a hit in April when they announced a key client would not be renewing in 2022. The blood and plasma services company provides collection devices, disposables and software solutions. As treatments and collections resume normal activity levels post-pandemic, it is anticipated growth will return to the company. It trades at 28x earnings, compared to peers over 41x. Over 95% of the stock is held by large institutions, allowing for greater staying power. We would purchase this with stop loss at $40, looking to achieve $98 -- upside potential over 70%. Yield 0% (Analysts’ price target is $97.33)
Healthcare
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Haemonetics Corporation(HAE-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Haemonetics Corporation is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Haemonetics Corporation(HAE-N) Frequently Asked Questions

What is Haemonetics Corporation stock symbol?

Haemonetics Corporation is a American stock, trading under the symbol HAE-N on the New York Stock Exchange (HAE). It is usually referred to as NYSE:HAE or HAE-N

Is Haemonetics Corporation a buy or a sell?

In the last year, there was no coverage of Haemonetics Corporation published on Stockchase.

Is Haemonetics Corporation a good investment or a top pick?

Haemonetics Corporation was recommended as a Top Pick by on . Read the latest stock experts ratings for Haemonetics Corporation.

Why is Haemonetics Corporation stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Haemonetics Corporation worth watching?

0 stock analysts on Stockchase covered Haemonetics Corporation In the last year. It is a trending stock that is worth watching.

What is Haemonetics Corporation stock price?

On 2024-10-10, Haemonetics Corporation (HAE-N) stock closed at a price of $74.45.